Guggenheim Capital’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-24,760
Closed -$492K 1734
2024
Q3
$492K Sell
24,760
-29,369
-54% -$584K ﹤0.01% 1413
2024
Q2
$838K Buy
+54,129
New +$838K 0.01% 1201
2023
Q4
Sell
-68,988
Closed -$806K 1886
2023
Q3
$806K Sell
68,988
-4,626
-6% -$54.1K 0.01% 1199
2023
Q2
$989K Buy
73,614
+10,551
+17% +$142K 0.01% 1160
2023
Q1
$1.05M Buy
63,063
+40,990
+186% +$680K 0.01% 1159
2022
Q4
$411K Buy
22,073
+9,871
+81% +$184K ﹤0.01% 1565
2022
Q3
$157K Buy
+12,202
New +$157K ﹤0.01% 1816
2018
Q2
Sell
-25,067
Closed -$59K 2414
2018
Q1
$59K Buy
25,067
+1,551
+7% +$3.65K ﹤0.01% 2698
2017
Q4
$91K Sell
23,516
-3,728
-14% -$14.4K ﹤0.01% 2609
2017
Q3
$68K Buy
27,244
+18
+0.1% +$45 ﹤0.01% 2674
2017
Q2
$74K Buy
27,226
+2,242
+9% +$6.09K ﹤0.01% 2713
2017
Q1
$49K Buy
24,984
+3,649
+17% +$7.16K ﹤0.01% 2736
2016
Q4
$22K Hold
21,335
﹤0.01% 2842
2016
Q3
$23K Sell
21,335
-260
-1% -$280 ﹤0.01% 2815
2016
Q2
$15K Sell
21,595
-1,760
-8% -$1.22K ﹤0.01% 2823
2016
Q1
$27K Sell
23,355
-5,789
-20% -$6.69K ﹤0.01% 2812
2015
Q4
$72K Buy
29,144
+9,665
+50% +$23.9K ﹤0.01% 2868
2015
Q3
$59K Sell
19,479
-417
-2% -$1.26K ﹤0.01% 2837
2015
Q2
$82K Buy
19,896
+8,541
+75% +$35.2K ﹤0.01% 2916
2015
Q1
$49K Buy
+11,355
New +$49K ﹤0.01% 2927
2014
Q3
Sell
-17,744
Closed -$45K 2963
2014
Q2
$45K Sell
17,744
-1,774
-9% -$4.5K ﹤0.01% 3046
2014
Q1
$44K Buy
19,518
+4,436
+29% +$10K ﹤0.01% 3094
2013
Q4
$29K Buy
15,082
+895
+6% +$1.72K ﹤0.01% 3038
2013
Q3
$43K Buy
14,187
+1,883
+15% +$5.71K ﹤0.01% 2889
2013
Q2
$11K Buy
+12,304
New +$11K ﹤0.01% 2928